Showing 1 - 5 results of 5 for search 'David P. Walling', query time: 0.04s Refine Results
  1. 1
    Pharmacokinetics and safety of deltoid or gluteal injection of aripiprazole lauroxil NanoCrystal Dispersion used for initiation of the long-acting antipsychotic aripiprazole lauroxil

    Pharmacokinetics and safety of deltoid or gluteal injection of aripiprazole lauroxil NanoCrystal Dispersion used for initiation of the long-acting antipsychotic aripiprazole laurox... by Marjie L. Hard, Angela Wehr, Lisa von Moltke, Yangchun Du, Sarah Farwick, David P. Walling, John Sonnenberg

    Published 2019-07-01
    Get full text
    Article
  2. 2
    Effects of the selective AMPA modulator NBI‐1065845 on the pharmacokinetics of midazolam or ethinyl estradiol–levonorgestrel in healthy adults

    Effects of the selective AMPA modulator NBI‐1065845 on the pharmacokinetics of midazolam or ethinyl estradiol–levonorgestrel in healthy adults by Swan Lin, Adrian Ionescu, Jessica Maynard‐Scott, Mike Kennedy, David P. Walling, Maura Furey, Jaskaran B. Singh

    Published 2024-05-01
    Get full text
    Article
  3. 3
    Population Pharmacokinetic Analysis to Support and Facilitate Switching from Risperidone Formulations to Rykindo in Patients with Schizophrenia

    Population Pharmacokinetic Analysis to Support and Facilitate Switching from Risperidone Formulations to Rykindo in Patients with Schizophrenia by Wenyan Wang, Xiaofeng Wang, Ying Dong, David P. Walling, Pinglan Liu, Wanhui Liu, Yanan Shi, Kaoxiang Sun

    Published 2024-01-01
    Get full text
    Article
  4. 4
    Efficacy of xanomeline and trospium chloride in schizophrenia: pooled results from three 5-week, randomized, double-blind, placebo-controlled, EMERGENT trials

    Efficacy of xanomeline and trospium chloride in schizophrenia: pooled results from three 5-week, randomized, double-blind, placebo-controlled, EMERGENT trials by Inder Kaul, Sharon Sawchak, Amy Claxton, Colin Sauder, Howard H. Hassman, Rishi Kakar, David P. Walling, Leslie Citrome, Haiyuan Zhu, Andrew C. Miller, Stephen K. Brannan

    Published 2024-11-01
    Get full text
    Article
  5. 5
    Proof-of-Mechanism Study of the Phosphodiesterase 10 Inhibitor RG7203 in Patients With Schizophrenia and Negative Symptoms

    Proof-of-Mechanism Study of the Phosphodiesterase 10 Inhibitor RG7203 in Patients With Schizophrenia and Negative Symptoms by Daniel Umbricht, Markus Abt, Paul Tamburri, Christopher Chatham, Štefan Holiga, Michael J. Frank, Anne G.E. Collins, David P. Walling, Rick Mofsen, Daniel Gruener, Lev Gertsik, Jeff Sevigny, Sanjay Keswani, Juergen Dukart

    Published 2021-06-01
    Get full text
    Article

Search Tools: